Chapter 24: Role of Gap Junctions in Cellular Growth Control and Neoplasia: Evidence and Mechanisms

Current Topics in Membranes and Transport

Volumn 49, Issue C, 1999, Pages 535-554

  Ruch, Randall J ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956693141     PISSN: 00702161     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2161(08)61028-X     Document Type: Article

References (109)

1. Albright C.D., Grimley P.M., Jones R.T., Fontana J.A., Keenan K.P., and Resau J.H. Cell-to-cell communication: A differential response to TGF-beta in normal and transformed (BEAS-2B) human bronchial epithelial cells. Carcinogenesis 12 (1991) 1993-1999
2. Beer D.G., Neveu M.J., Paul D.L., Rapp U.R., and Pitot H.C. Expression of the c-raf protooncogene, gamma-glutamyltranspeptidase, and gap junction protein in rat liver neoplasms. Cancer Res. 48 (1988) 1610-1617
3. Berthoud V.M., Rook M.B., Truab O., Hertzberg E.L., and Saez J.C. On the mechanisms of cell uncoupling induced by a tumor promoter phorbol ester in clone 9 cells, a rat liver epithelial cell line. Eur. J. Cell Biol. 62 (1993) 384-396
4. Blackburn J.P., Peters N.S., Yeh H.I., Rothery S., Green C.R., and Severs N.J. Upregulation of connexin43 gap junctions during early stages of human coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 1219-1228
5. Bone L.J., Deschenes S.M., Balice-Gordon R.J., Fischbeck K.H., and Scherer S.S. Connexin32 and X-linked Charcot-Marie-Tooth disease. Neurobiol. Dis. 4 (1997) 221-230
6. Brissette J.L., Kumar N.M., Gilula N.B., and Dotto G.P. The tumor promoter 12-O-tetradecanoylphorbol 13-acetate and the ras oncogene modulate expression and phosphorylation of gap junction proteins. Mol. Cell. Biol. 11 (1991) 5364-5371
7. Budunova I.V., and Williams G.M. Cell culture assays for chemicals with tumor promoting or inhibiting activity based on the modulation of intercellular communication. Cell Biol. Toxicol. 10 (1994) 71-116
8. Budunova I.V., Carbajal S., and Slaga T.J. The expression of gap junctional proteins during different stages of mouse skin carcinogenesis. Carcinogenesis 16 (1995) 2717-2724
9. Budunova I.V., Carbajal S., Viaje A., and Slaga T.J. Connexin expression in epidermal cell lines from SENCAR mouse skin tumors. Mol. Carcinog. 15 (1996) 190-201
10. Cesen-Cummings K., Fernstrom M.J., Malkinson A.M., and Ruch R.J. Frequent reduction of gap junctional intercellular communication and connexin43 expression in human and mouse lung carcinoma cells. Carcinogenesis 19 (1998) 61-67
11. Chaumontet C., Bex V., Gaillard-Sanchez I., Seillan-Heberden C., Suschetet M., and Martel P. Apigenin and tangeretin enhance gap junctional intercellular communication in rat liver epithelial cells. Carcinogenesis 15 (1994) 2325-2330
12. Chen S.C., Pelletier D.B., Ao P., and Boynton A.L. Connexin43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases. Cell Growth Differ. 6 (1995) 681-690
13. de Feijter A.W., Matesic D.F., Ruch R.J., Guan X., Chang C.C., and Trosko J.E. Localization and function of the connexin 43 gap-junction protein in normal and various oncogene-expressing rat liver epithelial cells. Mol. Carcinog. 16 (1996) 203-312
14. de Feijter-Rupp H.L., Hayashi T., Kalimi G.H., Edwards P., Redpath J.L., Chang C.C., Stanbridge E.J., and Trosko J.E. Restored gap junctional communication in non-tumorigenic HeLa-normal human fibroblast hybrids. Carcinogenesis 19 (1998) 747-754
15. Dermietzel R., Yancey S.B., Traub O., Willecke K., and Revel J.-P. Major loss of the 28-kD protein of gapjunction in proliferating hepatocytes. J. Cell. Biol. 105 (1987) 1925-1934
16. Duflot-Dancer A., Mesnil M., and Yamasaki H. Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes. Oncogene 15 (1997) 2151-2158
17. Eghbali B., Kessler J.A., Reid L.M., Roy C., and Spray D.C. Involvement of gap junctions in tumorigenesis: Transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc. Natl. Acad. Sci. USA 88 (1991) 10701-10705
18. Esinduy C., Chang C., Trosko J., and Ruch R. In vitro growth inhibition of neoplastically transformed cells by non-transformed cells: Requirement for gap junctional intercellular comunication. Carcinogenesis 16 (1995) 915-921
19. Fitzgerald D.J., Mesnil M., Oyamada M., Tsuda H., Ito N., and Yamasaki H. Changes in gap junction protein (connexin 32) gene expression during rat liver carcinogenesis. J. Cell. Biochem. 41 (1989) 97-102
20. Friedman E.A., and Steinberg M. Disrupted communication between late-stage premalignant human colon epithelial cells by 12-O-tetradecanoylphorbol 13-acetate. Cancer Res. 42 (1982) 5096-5105
21. Garber S.A., Fernstrom M.J., Stoner G.D., and Ruch R.J. Altered gap junctional intercellular communication in neoplastic rat esophageal epithelial cells. Carcinogenesis 18 (1997) 1149-1153
22. Giepmans B.N., and Moolenaar W.H. The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein. Curr. Biol. 8 (1998) 931-934
23. Goldberg G.S., Martyn K.D., and Lau A.F. A connexin 43 antisense vector reduces the ability of normal cells to inhibit the foci formation of transformed cells. Mol. Carcinog. 11 (1994) 106-114
24. Goldberg G.S., Moreno A.P., Bechberger J.F., Hearn S.S., Shivers R.R., MacPhee D.J., Zhang Y.C., and Naus C.C.G. Evidence that disruption of connexon particle arrangements in gap junction plaques is associated with inhibition of gap junctional communication by a glycyrrhetinic acid derivative. Exp. Cell Res. 222 (1996) 48-53
25. Gong X., Li E., Klier G., Huang Q., Wu Y., Lei H., Kumar N.M., Horwitz J., and Gilula N.B. Disruption of alpha3 connexin gene leads to proteolysis and cataractogenesis in mice. Cell 12 (1997) 833-843
26. Guan X.-J., and Ruch R.J. Gap junction endocytosis and lysosomal degradation of connexin43-P2 in WB-F344 rat liver epithelial cells treated with DDT and lindane. Carcinogenesis 17 (1996) 1791-1798
27. Guan X.-J., Wilson S., Schlender K.K., and Ruch R.J. Gap-junction disassembly and connexin 43 dephosphorylation induced by 18-β-glycyrrhetinic acid. Mol. Carcinog. 16 (1996) 157-164
28. Hirschi K.K., Xu C.E., Tsukamoto T., and Sager R. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ. 7 (1996) 861-870
29. Hossain M.Z., Ao P., and Boynton A.L. Platelet-derived growth factor-induced disruption of gap junctional communication and phosphorylation of connexin43 involves protein kinase C and mitogen-activated protein kinase. J. Cell. Physiol. 176 (1998) 332-341
30. Huang R.-P., Fan Y., Hossain M.Z., Peng A., Zeng Z.-L., and Boynton A.L. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res. 58 (1998) 5089-5096
31. Janssen-Timmen U., Traub O., Dermietzel R., Rabes H.M., and Willecke K. Reduced number of gap junctions in rat hepatocarcinomas detected by monoclonal antibody. Carcinogenesis 7 (1986) 1475-1482
32. Kalimi G.H., Hampton L.L., Trosko J.E., Thorgeirsson S.S., and Huggett A.C. Homologous and heterologous gap-junctional intercellular communication in v-raf-, v-myc-, and v-raf/v-myc-transduced rat liver epithelial cell lines. Mol. Carcinog. 5 (1992) 301-310
33. Kanemitsu M.Y., Jiang W., and Eckhart W. Cdc2-mediated phosphorylation of the gap junction protein, connexin43, during mitosis. Cell Growth Differ. 9 (1998) 13-21
34. Kam Y., Kim D.Y., Koo S.K., and Joe C.O. Transfer of second messengers through gap junction connexin 43 channels reconstituted in liposomes. Biochim. Biophys. Acta. 1372 (1998) 384-388
35. kip1) of cyclin-dependent kinase 4 activation. Cell 79 (1994) 487-496
36. Kelsell D.P., Dunlop J., Stevens H.P., Lench N.J., Liang J.N., Parry G., Mueller R.F., and Leigh I.M. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 387 (1997) 80-83
37. Klaunig J.E., and Ruch R.J. Role of intercellular communication in nongenotoxic carcinogenesis. Lab. Invest. 62 (1990) 135-146
38. Klaunig J.E., Ruch R.J., Hampton J.A., Weghorst C.M., and Hartnett J.A. Gap-junctional intercellular communication and murine hepatic carcinogenesis. Prog. Clin. Biol. Res. 331 (1990) 277-291
39. Klaunig J.E., Ruch R.J., and Weghorst C.M. Comparative effects of phenobarbital, DDT, and lindane on mouse hepatocyte gap junctional intercellular communication. Toxicol. Appl. Pharmacol. 102 (1990) 553-563
40. 0/S phase in clone 9 cells. Mol. Cell. Biochem. 167 (1997) 41-49
41. Krenacs T., and Rosendaal M. Connexin43 gap junctions in normal, regenerating, and cultured mouse bone marrow and in human leukemias: Their possible involvement in blood formation. Am. J. Pathol. 152 (1998) 993-1004
42. Krutovskikh V., Mazzoleni G., Mironov N., Omori Y., Aguelon A.M., Mesnil M., Berger F., Partensky C., and Yamasaki H. Altered homologous and heterologous gapjunctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int. J. Cancer 56 (1994) 87-94
43. Krutovskikh V.A., Mesnil M., Mazzoleni G., and Yamasaki H. Inhibition of rat liver gap junction intercellular communication by tumor-promoting agents in vivo. Association with aberrant localization of connexin proteins. Lab. Invest. 72 (1995) 571-577
44. Krutovskikh V., Mironov N., and Yamasaki H. Human connexin 37 is polymorphic but not mutated in tumours. Carcinogenesis 17 (1996) 1761-1763
45. Labarthe M.P., Bosco D., Saurat J.H., Meda P., and Salomon D. Upregulation of connexin 26 between keratinocytes of psoriatic lesions. J. Invest. Dermatol. 111 (1998) 72-76
46. L'Allemain G., Lavoie J.N., Rivard N., Baldin V., and Pouyssegur J. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts. Oncogene 14 (1997) 1981-1990
47. Lampe P.D., Kurata W.E., Warn-Cramer B.J., and Lau A.F. Formation of a distinct connexin43 phosphoisoform in mitotic cells is dependent upon p34cdc2 kinase. J. Cell. Sci. 111 (1998) 833-841
48. Lau A.F., Kurata W.E., Kanemitsu M.Y., Loo L.W., Warn-Cramer B.J., Eckhart W., and Lampe P.D. Regulation of connexin43 function by activated tyrosine protein kinases. J. Bioenerg. Biomembr. 28 (1996) 359-368
49. Lawrence T.S., Beers W.H., and Gilula N.B. Transmission of hormonal stimulation by cell-cell communication. Nature 272 (1978) 501-506
50. Lee S.W., Tomasetto C., Paul D., Keyomarsi K., and Sager R. Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J. Cell. Biol. 118 (1992) 1213-1221
51. Loch-Caruso R., and Trosko J.E. Inhibited intercellular communication as a mechanistic link between teratogenesis and carcinogenesis. CRC Crit. Rev. Toxicol. 16 (1986) 157-183
52. Loewenstein W.R. Junctional intercellular communication and the control of growth. Biochim. Biophys. Acta 560 (1979) 1-65
53. Loewenstein W.R., and Kanno Y. Intercellular communication and the control of growth. Lack of communication between cancer cells. Nature 209 (1966) 1248-1249
54. Martyn K.D., Kurata W.E., Warn-Cramer B.J., Burt J.M., TenBroek E., and Lau A.F. Immortalized connexin43 knockout cell lines display a subset of biological properties associated with the transformed phenotype. Cell Growth Differ. 8 (1997) 1015-1027
55. Matesic D.F., Rupp H.L., Bonney W.J., Ruch R.J., and Trosko J.E. Changes in gap-junction permeability, phosphorylation, and number mediated by phorbol ester and non-phorbol-ester tumor promoters in rat liver epithelial cells. Mol. Carcinog. 10 (1994) 226-236
56. Mehta P.P., Hotz-Wagenblatt A., Rose B., Shalloway D., and Loewenstein W.R. Incorporation of the gene for a cell-cell channel protein into transformed cells leads to normalization of growth. J. Memb. Biol. 124 (1991) 207-225
57. Mesnil M., Piccoli C., and Yamasaki H. An improved long-term culture of rat hepatocytes to detect liver tumour-promoting agents: Results with phenobarbital. Eur. J. Pharmacol. 248 (1993) 59-66
58. Mesnil M., Piccoli C., Klein J.L., Morand I., and Yamasaki H. Lack of correlation between the gap junctional communication capacity of human colon cancer cell lines and expression of the DCC gene, a homologue of a cell adhesion molecule (N-CAM). Jpn. J. Cancer Res. 84 (1993) 742-747
59. Mesnil M., Asamoto M., Piccoli C., and Yamasaki H. Possible molecular mechanism of loss of homologous and heterologous gap junctional intercellular communication in rat liver epithelial cell lines. Cell Adhes. Commun. 2 (1994) 377-384
60. Mesnil M., Krutovskikh V., Piccoli C., Elfgang C., Traub O., Willecke K., and Yamasaki H. Negative growth control of HeLa cells by connexin genes: Connexin species specificity. Cancer Res. 55 (1995) 629-639
61. Meyer D.J., Yancey S.B., Revel J.-P., and Peskoff A. Intercellular communication in normal and regenerating rat liver: A quantitative analysis. J. Cell Biol. 91 (1981) 505-523
62. Mikalsen S.O. Heterologous gap junctional intercellular communication in normal and morphologically transformed colonies of Syrian hamster embryo cells. Carcinogenesis 14 (1993) 2085-2090
63. Mironov N.M., Aguelon M.A., Potapova G.I., Omori Y., Gorbunov O.V., Klimenkov A.A., and Yamasaki H. Alterations of (CA)n DNA repeats and tumor suppressor genes in human gastric cancer. Cancer Res. 54 (1994) 41-44
64. Misra B.C., and Srivatsan E.S. Localization of HeLa cell tumor-suppressor gene to the long arm of chromosome II. Am. J. Hum. Genet. 45 (1989) 565-577
65. Murray A.W., and Fitzgerald D.J. Tumor promoters inhibit metabolic cooperation in cocultures of epidermal and 3T3 cells. Biochem. Biophys. Res. Commun. 91 (1979) 395-401
66. Murray S.A., and Fletcher W.H. Hormone-induced intercellular signal transfer dissociates cyclic amp-dependent protein kinase. J. Cell Biol. 98 (1984) 1710-1719
67. Naus C.C.G., Bechberger J.F., Zhang Y.C., Venance L., Yamasaki H., Juneja S.C., Kidder G.M., and Giaume C. Altered gap junctional communication, intercellular signaling, and growth in cultured astrocytes deficient in connexin43. J. Neurosci. Res. 49 (1997) 528-540
68. Omori Y., and Yamasaki H. Mutated connexin43 proteins inhibit rat glioma cell growth suppression mediated by wild-type connexin43 in a dominant-negative manner. Int. J. Cancer 78 (1998) 446-453
69. Omori Y., Duflot-Dancer A., Mesnil M., and Yamasaki H. Role of connexin (gap junction) genes in cell growth control: Approach with site-directed mutagenesis and dominant-negative effects. Toxicol. Lett. 96 (1998) 105-110
70. Omori Y., Krutovskikh V., Mironov N., Tsuda H., and Yamasaki H. Cx32 gene mutation in a chemically induced rat liver tumour. Carcinogenesis 17 (1996) 2077-2080
71. Oyamada M., Krutovskikh V.A., Mesnil M., Partensky C., Berger F., and Yamasaki H. Aberrant expression of gap junction gene in primary human hepatocellular carcinomas: Increased expression of cardiac-type gap junction gene connexin 43. Mol. Carcinog. 3 (1990) 273-278
72. Oyamada Y., Oyamada M., Fusco A., and Yamasaki H. Aberrant expression, function and localization of connexins in human esophageal carcinoma cell lines with different degrees of tumorigenicity. J. Cancer Res. Clin. Oncol. 120 (1994) 445-453
73. Oyoyo U.A., Shah U.S., and Murray S.A. The role of alphal (connexin-43) gap junction expression in adrenal cortical cell function. Endocrinology 138 (1997) 5385-5397
74. Pastan I.H., Johnson G.S., and Anderson W.B. Role of cyclic nucleotides in growth control. Annu. Rev. Biochem. 44 (1975) 491-522
75. Peters N.S., Green C.R., Poole-Wilson P.A., and Severs N.J. Cardiac arrhythmogenesis and the gap junction. J. Mol. Cell. Cardiol. 27 (1995) 37-44
76. Phipps M., Darozewski J., and Phipps J. How the neighborhood coherence principle (NCP) can give rise to tissue homeostasis: A cellular automaton approach. J. Theor. Biol. 185 (1997) 475-487
77. Piechocki M.P., Burk R.D., and Ruch R.J. Regulation of connexin32 and connexin43 gene expression by DNA methylation in rat liver cells. Carcinogenesis 20 (1999) 401-406
78. Pitot H.C., and Dragan Y.P. The multistage nature of chemically induced hepatocarcinogenesis in the rat. Drug Metab. Rev. 26 (1994) 209-220
79. Rae R.S., Mehta P.P., Chang C.C., Trosko J.E., and Ruch R.J. Neoplastic phenotype of gap-junctional intercellular communication-deficient WB rat liver epithelial cells and its reversal by forced expression of connexin 32. Mol. Carcinog. 22 (1998) 120-127
80. Reaume A.G., De Sousa P.A., Kulkarni S., Langille B.L., Zhu D., Davies T.C., Juenja S.C., Kidder G.M., and Rossant J. Cardiac malformation in neonatal mice lacking connexin43. Science 267 (1995) 1831-1834
81. Ren P., Mehta P.P., and Ruch R.J. Inhibition of gap junctional intercellular communication by tumor promoters in connexin43 and connexin32-expressing liver cells: Cell specificity and role of protein kinase C. Carcinogenesis 19 (1998) 169-175
82. Ren P., and Ruch R.J. Inhibition of gap junctional intercellular communication by barbiturates in long-term primary cultured rat hepatocytes is correlated with liver tumour promoting activity. Carcinogenesis 17 (1996) 2119-2124
83. Revel J.P., and Karnovsky M.J. Hexagonal array of subunits in intercellular junctions of the mouse heart and liver. J. Cell. Biol. 33 (1967) C7-C12
84. Ruch R.J. The role of gap junctional intercellular communication in neoplasia. Ann. Clin. Lab. Sci. 24 (1994) 216-231
85. Ruch R.J., and Klaunig J.E. Antioxidant prevention of tumor promoter induced inhibition of mouse hepatocyte intercellular communication. Cancer Lett. 33 (1986) 137-150
86. Ruch R.J., and Klaunig J.E. Kinetics of phenobarbital inhibition of intercellular communication in mouse hepatocytes. Cancer Res. 48 (1988) 2519-2523
87. Ruch R.J., Guan X.-J., and Sigler K. Inhibition of gap junctional intercellular communication and enhancement of growth in BALB/c 3T3 cells treated with connexin43 antisense oligonucleotides. Mol. Carcinog. 14 (1995) 269-274
88. Ruch R.J., Cesen-Cummings K., and Malkinson A.M. Role of gap junctions in lung neoplasia. Exp. Lung Res. 24 (1998) 523-539
89. Saito T., Barbin A., Omori Y., and Yamasaki H. Connexin 37 mutations in rat hepatic angiosarcomas induced by vinyl chloride. Cancer Res. 57 (1997) 375-377
90. Sawey M.J., Goldschmidt M.H., Risek B., Gilula N.B., and Lo C.W. Perturbation in connexin 43 and connexin 26 gap-junction expression in mouse skin hyperplasia and neoplasia. Mol. Carcinog. 17 (1996) 49-61
91. Shiokawa-Sawada M., Mano H., Hanada K., Kakudo S., Kameda T., Miyazawa K., Nakamaru Y., Yuasa T., Mori Y., Kumegawa M., and Hakeda Y. Down-regulation of gap junctional intercellular communication between osteoblastic MC3T3-E1 cells by basic fibroblast growth factor and a phorbol ester (12-O-tetradecanoylphorbol 13-acetate). J. Bone Miner. Res. 12 (1997) 1165-1173
92. Sigler K., and Ruch R.J. Enhancement of gap junctional intercellular communication in tumor promoter-treated cells by components of green tea. Cancer Lett. 69 (1993) 15-19
93. Simon A.M., Goodenough D.A., Li E., and Paul D.L. Female infertility in mice lacking connexin 37. Nature 385 (1997) 525-529
94. Statuto M., Audebet C., Tonoli H., Selmi-Ruby S., Rousset B., and Munari-Silem Y. Restoration of cell-to-cell communication in thyroid cell lines by transfection with and stable expression of the connexin-32 gene. Impact on cell proliferation and tissue-specific gene expression. J. Biol. Chem. 272 (1997) 24710-24716
95. Sugie S., Mori H., and Takahashi M. Effect of in vivo exposure to the liver tumor promoters phenobarbital or DDT on the gap junctions of rat hepatocytes: A quantitative freeze-fracture analysis. Carcinogenesis 8 (1987) 45-51
96. Temme A., Buchmann A., Gabriel H.D., Nelles E., Schwarz M., and Willecke K. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr. Biol. 7 (1997) 713-716
97. Toyofuku T., Yabuki M., Otsu K., Kuzuya T., Hori M., and Tada M. Direct association of the gap junction protein connexin-43 with ZO-1 in cardiac myocytes. J. Biol. Chem. 273 (1998) 12725-12731
98. Trosko J.E., Chang C.C., Madhukar B.V., and Klaunig J.E. Chemical, oncogene and growth factor inhibition of gap junctional intercellular communication: An integrative hypothesis of carcinogenesis. Pathobiology 58 (1990) 265-278
99. Upham B.L., Weis L.M., and Trosko J.E. Modulated gap junctional intercellular communication as a biomarker of PAH epigenetic toxicity: Structure-function relationship. Environ. Health Perspect. Suppl. 106 (1998) 975-981
100. van Zoelen E.J.J., and Tertoolen L.G.J. Transforming growth factor-β enhances the extent of intercellular communication between normal rat kidney cells. J. Biol. Chem. 266 (1991) 12075-12081
101. Warn-Cramer B.J., Cottrell G.T., Burt J.M., and Lau A.F. Regulation of connexin-43 gap junctional intercellular communication by mitogen-activated protein kinase. J. Biol. Chem. 273 (1998) 9188-9196
102. White T.W., Goodenough D.A., and Paul D.L. Targeted ablation of connexin50 in mice results in microphthalmia and zonular pulverulent cataracts. J. Cell. Biol. 143 (1998) 815-825
103. Wiemelt A.P., Engleka M.J., Skorupa A.F., and McMorris F.A. Immunochemical visualization and quantitation of cyclic AMP in single cells. J. Biol. Chem. 272 (1997) 31489-31495
104. Wilgenbus K.K., Kirkpatrick C.J., Knuechel R., Willecke K., and Traub O. Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int. J. Cancer 51 (1992) 522-529
105. Willecke K., Jungbluth S., Dahl E., Hennemann H., Heynkes R., and Grzeschik K.H. Six genes of the human connexin gene family coding for gap junctional proteins are assigned to four different human chromosomes. Eur. J. Cell. Biol. 53 (1990) 275-280
106. Yamasaki H., and Naus C.C. Role of connexin genes in growth control. Carcinogenesis 17 (1996) 1199-1213
107. Yotti L.P., Chang C.C., and Trosko J.E. Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science 206 (1979) 1089-1091
108. Zhu D., Caveney S., Kidder G.M., and Naus C.C.G. Transfection of C6 glioma cells with connexin 43 cDNA: Analysis of expression, intercellular coupling, and cell proliferation. Proc. Natl. Acad. Sci., USA 88 (1991) 1883-1887
109. Zhu W.B., Mironov N., and Yamasaki H. Hypermethylation of connexin32 gene as a mechanism of disruption of cell-cell communication in tumors. Proc. Am. Assoc. Cancer Res. 39 (1998) 199